Injection-site reactions (ISRs) are common adverse reactions to biological drugs, consisting of itching, erythema and induration at the injection site.1 ISRs usually appear within 24–48 h of injection and subside within a few days. They typically occur in the first 2 months of treatment and subsequently decrease in frequency; incidence varies by drug. While ISRs seldom result in discontinuation of treatment, they remain a safety concern when using biological drugs.
Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study.
Girolomoni, G;
2018-01-01
Abstract
Injection-site reactions (ISRs) are common adverse reactions to biological drugs, consisting of itching, erythema and induration at the injection site.1 ISRs usually appear within 24–48 h of injection and subside within a few days. They typically occur in the first 2 months of treatment and subsequently decrease in frequency; incidence varies by drug. While ISRs seldom result in discontinuation of treatment, they remain a safety concern when using biological drugs.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Girolomoni G Comparison of injection-site reactions BJD 2018.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Accesso ristretto
Dimensione
150.59 kB
Formato
Adobe PDF
|
150.59 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
